H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 76 Citations 18,065 321 World Ranking 775 National Ranking 6
Medicine D-index 80 Citations 21,343 322 World Ranking 9413 National Ranking 25

Research.com Recognitions

Awards & Achievements

1989 - Fellow of the American Association for the Advancement of Science (AAAS)

1976 - Member of the National Academy of Sciences

1971 - Fellow of the American Academy of Arts and Sciences

Member of the European Academy of Sciences and Arts

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Biochemistry

Michael Sela mainly focuses on Biochemistry, Molecular biology, Antibody, Antigen and Immunology. His work deals with themes such as Antigenicity and Immunogenicity, which intersect with Biochemistry. His work carried out in the field of Molecular biology brings together such families of science as Cell, Antigen-presenting cell, Myelin basic protein, Receptor tyrosine kinase and Epitope.

The Monoclonal antibody research Michael Sela does as part of his general Antibody study is frequently linked to other disciplines of science, such as Conjugate, therefore creating a link between diverse domains of science. His Monoclonal antibody study combines topics in areas such as Receptor, Epidermal growth factor, Epidermal growth factor receptor, ErbB and Cell growth. His Antigen research incorporates themes from Autoimmunity, Gene and Bovine serum albumin.

His most cited work include:

  • THE KINETICS OF FORMATION OF NATIVE RIBONUCLEASE DURING OXIDATION OF THE REDUCED POLYPEPTIDE CHAIN (876 citations)
  • Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. (709 citations)
  • Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. (491 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Antibody, Biochemistry, Molecular biology, Antigen and Immunology. His Antibody research focuses on subjects like In vitro, which are linked to In vivo. His study in Amino acid, Alanine, Peptide, Ribonuclease and Bovine serum albumin is carried out as part of his Biochemistry studies.

In his study, which falls under the umbrella issue of Molecular biology, Acetylcholine receptor is strongly linked to T cell. As part of one scientific family, he deals mainly with the area of Antigen, narrowing it down to issues related to the Tyrosine, and often Glutamic acid. His study ties his expertise on Myelin basic protein together with the subject of Immunology.

He most often published in these fields:

  • Antibody (30.36%)
  • Biochemistry (31.35%)
  • Molecular biology (27.56%)

What were the highlights of his more recent work (between 1995-2020)?

  • Immunology (17.00%)
  • Multiple sclerosis (7.43%)
  • Molecular biology (27.56%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, Multiple sclerosis, Molecular biology, T cell and Experimental autoimmune encephalomyelitis. His work is dedicated to discovering how Immunology, Myelin basic protein are connected with Adoptive cell transfer and other disciplines. His studies in Molecular biology integrate themes in fields like Receptor, Biochemistry, Peptide, Epitope and Monoclonal antibody.

His Biochemistry research is mostly focused on the topic Amino acid. His Antibody research includes elements of Endocytosis and Immunotherapy. Immune system connects with themes related to Antigen in his study.

Between 1995 and 2020, his most popular works were:

  • Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. (709 citations)
  • Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. (491 citations)
  • The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors (382 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Antibody

His primary scientific interests are in Immunology, Multiple sclerosis, T cell, Experimental autoimmune encephalomyelitis and Molecular biology. In his work, Adoptive cell transfer and Cytokine is strongly intertwined with Myelin basic protein, which is a subfield of Immunology. His Multiple sclerosis research is multidisciplinary, incorporating perspectives in Autoimmunity, Pharmacology and Antigen.

His T cell research includes themes of Biochemistry, CD8, Spleen, Major histocompatibility complex and FOXP3. His Molecular biology research is multidisciplinary, relying on both Cancer research and Receptor tyrosine kinase, Signal transduction, ErbB. His Antibody study focuses on Monoclonal antibody in particular.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

THE KINETICS OF FORMATION OF NATIVE RIBONUCLEASE DURING OXIDATION OF THE REDUCED POLYPEPTIDE CHAIN

Christian B. Anfinsen;Edgar Haber;Michael Sela;F. H. White.
Proceedings of the National Academy of Sciences of the United States of America (1961)

1410 Citations

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

R Pinkas-Kramarski;L Soussan;H Waterman;G Levkowitz.
The EMBO Journal (1996)

973 Citations

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

L N Klapper;M H Kirschbaum;M Sela;Y Yarden.
Advances in Cancer Research (2000)

757 Citations

Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth

Ilana Stancovski;Esther Hurwitz;Orit Leitner;Axel Ullrich.
Proceedings of the National Academy of Sciences of the United States of America (1991)

661 Citations

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.

Dvora Teitelbaum;A. Meshorer;T. Hirshfeld;Ruth Arnon.
European Journal of Immunology (1971)

599 Citations

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

Leah N. Klapper;Stefanie Glathe;Nora Vaisman;Nancy E. Hynes.
Proceedings of the National Academy of Sciences of the United States of America (1999)

584 Citations

Antigenicity: some molecular aspects.

Michael Sela.
Science (1969)

584 Citations

A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

Murray B. Bornstein;Aaron Miller;Susan Slagle;Muriel Weitzman.
The New England Journal of Medicine (1987)

580 Citations

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Anne E.G. Lenferink;Ronit Pinkas‐Kramarski;Monique L.M. van de Poll;Marianne J.H. van Vugt.
The EMBO Journal (1998)

546 Citations

Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.

Hugh O. McDevitt;Michael Sela.
Journal of Experimental Medicine (1965)

515 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael Sela

Yosef Yarden

Yosef Yarden

Weizmann Institute of Science

Publications: 129

Ruth Arnon

Ruth Arnon

Weizmann Institute of Science

Publications: 101

Michal Schwartz

Michal Schwartz

Weizmann Institute of Science

Publications: 88

Harold A. Scheraga

Harold A. Scheraga

Cornell University

Publications: 54

Edna Mozes

Edna Mozes

Weizmann Institute of Science

Publications: 53

Jonathan Kipnis

Jonathan Kipnis

Washington University in St. Louis

Publications: 47

Lawrence Steinman

Lawrence Steinman

Stanford University

Publications: 37

Zelig Eshhar

Zelig Eshhar

Tel Aviv Sourasky Medical Center

Publications: 37

Hockin H.K. Xu

Hockin H.K. Xu

University of Maryland, Baltimore

Publications: 37

Ronald T. Raines

Ronald T. Raines

MIT

Publications: 36

Meir Wilchek

Meir Wilchek

Weizmann Institute of Science

Publications: 34

Christian B. Anfinsen

Christian B. Anfinsen

National Institutes of Health

Publications: 34

José Baselga

José Baselga

Memorial Sloan Kettering Cancer Center

Publications: 34

Carlos L. Arteaga

Carlos L. Arteaga

The University of Texas Southwestern Medical Center

Publications: 32

Vladimir N. Uversky

Vladimir N. Uversky

University of South Florida

Publications: 32

Kermit L. Carraway

Kermit L. Carraway

University of California, Davis

Publications: 30

Something went wrong. Please try again later.